title: Uterine artery embolization combined with intra-arterial MTX infusion: its application in treatment of cervical pregnancy.
abstract: OBJECTIVE
  To investigate the efficacy and safety of uterine artery chemoembolization (UAE) combined with intra-arterial MTX infusion for the treatment of cervical pregnancy.
  
  
  METHODS
  Retrospective chart review for 26 cervical pregnancy patients treated at Renji hospital between January 2000 and December 2012. 14 patients received UAE combined with intra-arterial MTX infusion (UAE group) and 12 patients received single intramuscular MTX injection combined with subsequent uterine curettage (non-UAE group).
  
  
  RESULTS
  All 14 patients in the UAE group were treated successfully and 1 patient in the non-UAE group had 1200 ml vaginal bleeding during uterine curettage and was then treated with emergency UAE. The mean estimated blood loss during uterine curettage in the UAE group was much less than in non-UAE Group. A quicker regression of serum β-hCG level and normal menses resumed and a shorter hospital stay were observed in the UAE group than in the non-UAE group.
  
  
  CONCLUSIONS
  Uterine artery chemoembolization combined with intra-arterial MTX infusion is an efficient conservative treatment for cervical pregnancy.
authors.affiliation: Department of Obstetrics and Gynecology, RenJi Hospital, Shanghai Jiao-Tong University School of Medicine, 1630 Dong Fang Road, Shanghai, 200127, China. drzhangshu@126.com.
authors.forename: Shu
authors.initials: S
authors.lastname: Zhang
authors.affiliation: Department of Obstetrics and Gynecology, RenJi Hospital, Shanghai Jiao-Tong University School of Medicine, 1630 Dong Fang Road, Shanghai, 200127, China.
authors.forename: Huan
authors.initials: H
authors.lastname: Yan
authors.affiliation: Department of Obstetrics and Gynecology, RenJi Hospital, Shanghai Jiao-Tong University School of Medicine, 1630 Dong Fang Road, Shanghai, 200127, China.
authors.forename: Wen-Ting
authors.initials: WT
authors.lastname: Ji
mesh_terms: D000328:Adult; D002585:Cesarean Section / Q000009:adverse effects; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D004107:Dilatation and Curettage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial; D007273:Injections, Intramuscular; D008727:Methotrexate / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000601:surgery*; D012189:Retrospective Studies; D016896:Treatment Outcome; D055357:Uterine Artery Embolization; D014592:Uterine Hemorrhage / Q000209:etiology; D055815:Young Adult
chemical_list: D008727:Methotrexate
keywords: Cervical pregnancy; Methotrexate; Uterine artery embolization